Sodium–Glucose Cotransporter 2 Inhibitors as Potential Antioxidant Therapeutic Agents in Cardiovascular and Renal Diseases is a research paper published in Antioxidants (2025). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01-DK-114663
National Institutes of Health
Grant: R01-DK-129311
National Institutes of Health
Grant: 5R01DK129311-03
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
National Institutes of Health
Grant: 5R01DK114663-04
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure
FWCI
3.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords